| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $919K | +375.1% |
| Cost of Revenue | $619K | +466.1% |
| R&D Expense | $2.5M | +15.2% |
| SG&A Expense | $2.4M | -9.7% |
| Operating Income | -$4.6M | +17.2% |
| Pre-tax Income | -$4.6M | +15.2% |
| Net Income | -$4.6M | +15.2% |
| EPS (Basic) | -$0.37 | +21.3% |
| EPS (Diluted) | -$0.37 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -74.5% |
| Accounts Receivable | $60K | -68.3% |
| Current Assets | $1.4M | -73.9% |
| Total Assets | $3.8M | -46.3% |
| Current Liabilities | $627K | -17.2% |
| Total Liabilities | $1.6M | +48.8% |
| Stockholders' Equity | $2.3M | -62.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +5.0% |
| Capital Expenditures | $322K | -45.5% |
| Investing Cash Flow | -$322K | +52.1% |
| Financing Cash Flow | -$4K | -100.1% |
| Free Cash Flow | -$3.8M | +10.7% |
| +21.3% |